Education
About Us
Working with TipRanks
Follow Us
GlucoTrack (GCTK)
NASDAQ:GCTK
GCTK Stock Chart & Stats
Day’s Range― - ―
52-Week Range$0.13 - $99.00
Previous Close$0.14
Volume195.77M
Average Volume (3M)6.46M
Market Cap
$3.81M
Enterprise Value-$1.89M
Total Cash (Recent Filing)$1.90M
Total Debt (Recent Filing)$606.14K
Price to Earnings (P/E)―
Beta0.91
Next EarningsN/A
EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)-68.06
Shares Outstanding25,585,854
10 Day Avg. Volume3,552,562
30 Day Avg. Volume6,458,045
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)N/A
Price to Sales (P/S)N/A
Price to Cash Flow (P/CF)-0.10
P/FCF Ratio0.00
Enterprise Value/Market Cap-0.50
Enterprise Value/RevenueN/A
Enterprise Value/Gross Profit145.23
Enterprise Value/Ebitda0.14
Forecast
1Y Price TargetN/A
Price Target UpsideN/A
Rating ConsensusN/A
Number of Analyst Covering0
---
GlucoTrack News
PremiumCompany Announcements
GlucoTrack Partners with OneTwo Analytics for AI-Driven Insights
PremiumCompany Announcements
Glucotrack Reports Transformative Year with Clinical Advances
PremiumCompany Announcements
GlucoTrack Advances with Clinical Trials and Funding Boost
PremiumCompany Announcements
GlucoTrack to Present Data on New Glucose Monitoring System
PremiumCompany Announcements
GlucoTrack Appoints Dr. Umpierrez to Advisory Board
---
Ownership Overview
5.86% Insiders
0.25%
Mutual Funds
0.09% Other Institutional Investors
93.88% Public Companies and
Individual Investors
Risk Analysis
Main Risk Category
Tech & InnovationRisks related to the company’s reliance on technology and ability to make innovative products
GCTK FAQ
What was GlucoTrack’s price range in the past 12 months?
GlucoTrack lowest stock price was $0.13 and its highest was $99.00 in the past 12 months.
What is GlucoTrack’s market cap?
GlucoTrack’s market cap is $3.81M.
When is GlucoTrack’s upcoming earnings report date?
The company’s upcoming earnings report date is not yet available.
How were GlucoTrack’s earnings last quarter?
GlucoTrack released its earnings results on May 15, 2018. The company reported -$4.363 earnings per share for the quarter, missing the consensus estimate of N/A by -$4.363.
Is GlucoTrack overvalued?
According to Wall Street analysts GlucoTrack’s price is currently Overvalued.
Does GlucoTrack pay dividends?
GlucoTrack does not currently pay dividends.
What is GlucoTrack’s EPS estimate?
GlucoTrack’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does GlucoTrack have?
GlucoTrack has 25,585,854 shares outstanding.
What happened to GlucoTrack’s price movement after its last earnings report?
GlucoTrack reported an EPS of -$4.363 in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went up 29.412%.
Which hedge fund is a major shareholder of GlucoTrack?
Currently, no hedge funds are holding shares in GCTK
---
GlucoTrack Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Insider Transactions
Bought Shares
Worth $301.3K over
the Last 3 Months
the Last 3 Months
Crowd Wisdom
Very Positive
Last 7 Days ▼ 1.2%
Last 30 Days ▲ 6.6%
Last 30 Days ▲ 6.6%
News Sentiment
Neutral
Bullish news 50%
Bearish news 50%
Bearish news 50%
Technicals
SMA
Negative
20 days / 200 days
Momentum
-99.71%
12-Months-Change
Fundamentals
Return on Equity
-1943.32%
Trailing 12-Months
Asset Growth
20.94%
Trailing 12-Months
Company Description
GlucoTrack
GlucoTrack (GCTK) is a medical technology company specializing in the development and commercialization of innovative glucose monitoring devices. The company focuses on providing non-invasive solutions for individuals managing diabetes, aiming to enhance their quality of life through advanced technology. GlucoTrack's core product is a non-invasive glucose measurement device designed to offer an alternative to traditional finger-stick testing, thus providing a more comfortable and convenient monitoring experience for users.
---
Technical Analysis
---